Review
Accepted on 18 Jul 2025
Dexmedetomidine and the Glymphatic System: A New Perspective in Managing Postoperative Cognitive Dysfunction
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1648308
Type at least 3 characters
2,486 articles
Opinion
Published on 18 Jul 2025
Several endocannabinoids and amino acids may be biosynthetically converted to catecholamines in vivo
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1614460
- 300 views
Correction
Published on 18 Jul 2025
Correction: The antipsychotics functional index (AFI) in schizophrenia
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1662228
- 130 views
Review
Published on 18 Jul 2025
Genetic implication of GABAB receptors in the etiology of neurological and psychiatric disorders
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1634128
- 363 views
Original Research
Accepted on 17 Jul 2025
Neurological Adverse Events Associated with Antidepressants: A Comprehensive 22-Year Analysis of the FDA Adverse Event Reporting System
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1644241
Original Research
Accepted on 17 Jul 2025
Assessment of Drug-Related Migraine in a Real-World Large-Scale Database
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1647088
Original Research
Accepted on 16 Jul 2025
Ineffectiveness of Tirzepatide in Mitigating Doxorubicin-Induced Oxidative Stress and Cognitive Deficits in a Rat Model
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1638527
Review
Published on 16 Jul 2025
Pharmacological mechanisms and potential clinical applications of Dihydromyricetin in neurological disorders
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1618623
- 364 views
Review
Published on 16 Jul 2025
Cerebral ischemia-reperfusion injury: mechanisms and promising therapies
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1613464
- 369 views
Case Report
Accepted on 15 Jul 2025
Successful Treatment of spondyloenchondrodysplasia with Immune Dysregulation Using Tofacitinib and Ruxolitinib: A Report of Two Pediatric Cases
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1588003
Original Research
Accepted on 14 Jul 2025
Identification of potential drug-induced neuralgia signals through disproportionality analysis of the FAERS database
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1645114
Correction
Published on 11 Jul 2025
Correction: Novel multitarget analgesic candidate SZV-1287 demonstrates potential disease-modifying effects in the monoiodoacetate-induced osteoarthritis mouse model
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1646562
- 386 views
Original Research
Published on 11 Jul 2025
Ursolic acid ameliorates cerebral ischemia-reperfusion injury by inhibiting NF-κB/NLRP3-mediated microglia pyroptosis and neuroinflammation
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1622131
- 368 views
Original Research
Published on 11 Jul 2025
Ramipril and ketogenic diet response in cognitive dysfunction of insulin-resistant rats
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1620139
- 361 views
Original Research
Accepted on 09 Jul 2025
Synergistic effects of combined hypnotic drugs on sleep in mice
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1596813
- 182 views
Original Research
Accepted on 09 Jul 2025
α-Lipoic acid mitigates age-related macular degeneration via ferroptosis: integrative multi-omics and network pharmacology
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1626907
- 137 views